Search results for "Diabetes"
Tailoring diabetes screening by race, ethnicity may lead to earlier diagnosis
Researchers used data from the National Health and Nutrition Examination Survey to determine the body mass index and age thresholds for diabetes screening in major racial/ethnic minority populations.
https://immattersacp.org/weekly/archives/2022/05/10/1.htm
10 May 2022
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
KDIGO guideline summary provides key points for treating diabetes, chronic kidney disease
Authors from the Kidney Disease: Improving Global Outcomes (KDIGO) Work Group provided a synopsis of key recommendations on comprehensive care, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.
https://immattersacp.org/weekly/archives/2023/01/10/1.htm
10 Jan 2023
Some newer diabetes drugs may help decrease risk of COPD exacerbation
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://immattersacp.org/weekly/archives/2022/11/08/4.htm
8 Nov 2022
Type of insulin may affect hypoglycemia rates in older adults with type 2 diabetes, study finds
Risk may be lower with long-acting insulin analogs versus neutral protamine Hagedorn (NPH) insulin.
https://immattersacp.org/weekly/archives/2021/03/09/4.htm
9 Mar 2021
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/12/06/3.htm
6 Dec 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2023
Warfarin recalled, type 2 diabetes drug approved
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/07/fda.htm
1 Jul 2011
Experts offer advice on oral drugs, insulin for diabetes
Any type 2 diabetic is eventually going to need oral medications, and some on oral medications may eventually progress to needing insulin. The regimens are complex and vary from patient to patient. Learn how to individually tailor such decisions.
https://immattersacp.org/archives/2011/06/diabetes.htm
1 Jun 2011
Nearly 50% of older U.S. adults reported taking aspirin preventively
A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://immattersacp.org/weekly/archives/2021/06/29/4.htm
29 Jun 2021